Should Patients with Kidney Stones Avoid GLP-1 Agonists
and 82201576 to Yun Z.), the Key Laboratory of Alzheimers Disease of Zhejiang Province (ZJAD-2021004 to Yun Z.) and STI2030-Major Projects (2022ZD0211800 to Yun Z.)
You should contact your GP or healthcare professional if you experience: Heavy bleeding (soaking through a pad or tampon every hour for several consecutive hours) or passing large clots Prolonged bleeding lasting more than seven days or bleeding that does not stop Severe pelvic or abdominal pain that is new, persistent, or worsening Postmenopausal bleeding (any vaginal bleeding occurring 12 months or more after your last period) this requires an urgent 2-week suspected cancer referral [11] Bleeding between periods that is recurrent, increasing in frequency, or accompanied by other concerning symptoms Signs of anaemia , such as extreme fatigue, dizziness, shortness of breath, or pale skin It is also important to seek advice if you have missed periods and there is any possibility of pregnancy
Find out more here - GLP-1 agonists linked to pancreatitis: report and MHRA guidance Use of GLP-1 agonists is increasing both through NHS and private prescriptions
Standards of medical care for type 2 diabetes in China 2019
To further enhance in vivo stability and targeting precision, alternative conjugation strategies such as thiol-maleimide crosslinking, click chemistry, or multivalent ligand design could be employed